Microfluidic devices, and methods of making and using the same

• US 10,073,093 B2
• Filed: 09/13/2017
• Issued: 09/11/2018
• Est. Priority Date: 11/06/2013
• Status: Active Grant

• Current Assignee: Becton, Dickinson & Co
• Original Assignee: Becton, Dickinson & Co
• Inventors: Bornheimer, Scott Joseph, Sugarman, Jeffrey, Huang, Wei, Goldberg, Edward Michael, Tan, Ming
• Primary Examiner(s): Gabel, Gailene
• Application Number:
  US15/703,928
• Publication Number:
  US 20180011090A1
• Time in Patent Office: 363 Days
• CPC Class Codes: B01F 2215/0431 Numerical size values, e.g. diameter of a hole or conduit, area, volume, length, width, or ratios thereof
• CPC Class Codes: B01F 25/4522 the components being pressed through porous bodies, e.g. flat plates, blocks or cylinders, which obstruct the whole diameter of the tube B01F25/45243 takes precedence
• CPC Class Codes: B01F 33/30 Micromixers
• CPC Class Codes: B01F 33/301 using specific means for arranging the streams to be mixed, e.g. channel geometries or dispositions
• CPC Class Codes: B01L 2200/16 Reagents, handling or storing thereof
• CPC Class Codes: B01L 2300/0816 Cards, e.g. flat sample carriers usually with flow in two horizontal directions
• CPC Class Codes: B01L 2400/0406 capillary forces
• CPC Class Codes: B01L 2400/086 using baffles or other fixed flow obstructions
• CPC Class Codes: B01L 3/5023 with a sample being transported to, and subsequently stored in an absorbent for analysis
• CPC Class Codes: B01L 3/502746 characterised by the means for controlling flow resistance, e.g. flow controllers, baffles B01L3/502738 takes precedence
• CPC Class Codes: G01N 33/558 using diffusion or migration of antigen or antibody immunochromatographic test strips G01N33/54387

Abstract

The present disclosure provides methods and systems for assaying a sample. A microfluidic device to perform an assay of a sample (e.g., biological sample) is described having a sample application site, a porous component and a flow channel. The porous component provides for uniform dissolution of a reagent and mixing of the sample and reagent without filtering the sample.

Claims

1. An assay method using a microfluidic device;

the method comprising;

(a) providing a microfluidic device comprising;

a sample application site;

a flow channel in fluid communication with the sample application site; and

a porous component positioned between the sample application site and flow channel, wherein the porous component comprises a porous matrix comprising pores and an assay reagent comprising an analyte-specific optically detectable label positioned within the pores of the porous matrix;

(b) contacting a sample to the sample application site so that the sample flows through the porous matrix and into the flow channel, wherein the porous matrix is configured to mix the sample with the assay reagent to produce a labelled sample that then flows into the flow channel;

(c) illuminating the labelled sample in the flow channel with a light source; and

(d) detecting light from the labelled sample.

2. The method according to claim 1, wherein the analyte-specific optically detectable label comprises an analyte-specific binding member conjugated to an optically detectable label.

3. The method according to claim 2, wherein the analyte-specific binding member is an antibody or antibody fragment.

4. The method according to claim 3, wherein the antibody or antibody fragment specifically binds to a target selected from the group consisting of CD14, CD4, CD45RA, CD3 and a combination thereof.

5. The method according to claim 2, wherein the optically detectable label comprises a fluorescent dye.

6. The method according to claim 5, wherein the fluorescent dye comprises a compound selected from the group consisting of rhodamine, coumarin, cyanine, xanthene, polymethine, pyrene, dipyrromethene borondifluoride, napthalimide, phycobiliprotein, peridinium chlorophyll proteins, conjugates thereof and a combination thereof.

7. The method according to claim 1, wherein 95% or greater of the sample passes through the porous matrix into the flow channel.

8. The method according to claim 1, wherein the method comprises illuminating the sample with a broad spectrum light source.

9. The method according to claim 8, wherein the broad spectrum light source comprises an ultraviolet light source and a visible light source.

10. The method according to claim 8, wherein the method comprises illuminating the sample with light having a wavelength between 200 nm and 800 nm.

11. The method according to claim 1, wherein detecting light from the labelled sample comprises capturing an image of the sample in the flow channel.

12. The method according to claim 1, wherein the sample is a biological fluid.

13. The method according to claim 12, wherein the biological fluid is whole blood.

14. The method according to claim 12, wherein the biological fluid is plasma.

15. The method according to claim 1, wherein the assay reagent is positioned within the pores of the porous matrix.

16. The method according to claim 15, wherein the assay reagent is dry.

17. The method according to claim 1, wherein the porous matrix comprises pores having diameters between 1 μ

m and 200 μ

m.

18. An assay method using a microfluidic device;

the method comprising;

contacting a sample to a sample application site of a microfluidic device, the microfluidic device comprising;

a flow channel in fluid communication with the sample application site; and

a porous component positioned between the sample application site and flow channel, wherein the porous component comprises a porous matrix and an assay reagent;

wherein the porous matrix comprises pores;

wherein the assay reagent is positioned within the pores of the porous reagent; and

wherein the porous matrix is configured to mix the sample with the assay reagent to produce a labeled sample that flows into the flow channel.

19. The method according to claim 18, wherein the assay reagent comprises an analyte-specific binding member conjugated to an optically detectable label.

20. The method according to claim 19, wherein the analyte-specific binding member is an antibody or antibody fragment.